Screener
Vaxcyte, Inc. PCVX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001649094-26-000017
| Line item | March 31,2026 | December 31, 2025 |
|---|---|---|
| Restricted cash | 1,466 | 1,466 |
| Other assets | 155,539 | 118,847 |
| Total noncurrent assets | 1,534,820 | 1,375,356 |
| Total assets | $3,348,308 | $3,002,717 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $63,060 | $70,904 |
| Accrued compensation | 7,986 | 23,000 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Vaxcyte, Inc.'s total assets?
- Vaxcyte, Inc. (PCVX) reported total assets of $3.35B in Q1 2026.
- How has Vaxcyte, Inc.'s total assets changed year-over-year?
- Vaxcyte, Inc.'s total assets decreased by 0.9% year-over-year, from $3.38B to $3.35B.
- What is the long-term trend for Vaxcyte, Inc.'s total assets?
- Over 5 years (2020 to 2025), Vaxcyte, Inc.'s total assets has grown at a 50.2% compound annual growth rate (CAGR), from $392.83M to $3B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Vaxcyte, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude